Junshi Bio Terminates 2026 A-Share Employee Stock Ownership Scheme

Bulletin Express

Aug 26

Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio) announced that its Board of Directors has resolved to terminate the 2026 A-Share Employee Stock Ownership Scheme (ESOP) with immediate effect. The decision covers the cancellation of the ESOP itself, its administrative measures and all ancillary documents that had been adopted on 27 April 2026.

According to the company, the termination aims to better safeguard the interests of the company, its shareholders and its employees. Junshi Bio stated that the move is fully compliant with the “Guidance Opinions on the Pilot Implementation of Employee Stock Ownership Plan by Listed Companies” and the Shanghai Stock Exchange’s STAR Market self-regulation guidelines.

Management emphasized that ending the 2026 ESOP will not affect the company’s development strategy, business plans, financial position or operating results. The board further noted that no circumstances detrimental to shareholders’ interests have arisen from this decision.

Looking ahead, Junshi Bio plans to continue refining its long-term incentive mechanisms in line with regulatory requirements, market conditions and the company’s operational needs to support sustainable growth.

The resolution was approved by the Board on 26 August 2026 under the chairmanship of Mr. Xiong Jun.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/news/1114052435"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1114052435\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1114052435?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-26 18:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1114052435","market":"us","top_or_hot":-1,"title":"Junshi Bio Terminates 2026 A-Share Employee Stock Ownership Scheme","media":"Bulletin Express","content":"<p>Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio) announced that its Board of Directors has resolved to terminate the 2026 A-Share Employee Stock Ownership Scheme (ESOP) with immediate effect. The decision covers the cancellation of the ESOP itself, its administrative measures and all ancillary documents that had been adopted on 27 April 2026.</p>\n<p>According to the company, the termination aims to better safeguard the interests of the company, its shareholders and its employees. Junshi Bio stated that the move is fully compliant with the “Guidance Opinions on the Pilot Implementation of Employee Stock Ownership Plan by Listed Companies” and the Shanghai Stock Exchange’s STAR Market self-regulation guidelines.</p>\n<p>Management emphasized that ending the 2026 ESOP will not affect the company’s development strategy, business plans, financial position or operating results. The board further noted that no circumstances detrimental to shareholders’ interests have arisen from this decision.</p>\n<p>Looking ahead, Junshi Bio plans to continue refining its long-term incentive mechanisms in line with regulatory requirements, market conditions and the company’s operational needs to support sustainable growth.</p>\n<p>The resolution was approved by the Board on 26 August 2026 under the chairmanship of Mr. Xiong Jun.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Junshi Bio Terminates 2026 A-Share Employee Stock Ownership Scheme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJunshi Bio Terminates 2026 A-Share Employee Stock Ownership Scheme\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-26 18:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio) announced that its Board of Directors has resolved to terminate the 2026 A-Share Employee Stock Ownership Scheme (ESOP) with immediate effect. The decision covers the cancellation of the ESOP itself, its administrative measures and all ancillary documents that had been adopted on 27 April 2026.</p>\n<p>According to the company, the termination aims to better safeguard the interests of the company, its shareholders and its employees. Junshi Bio stated that the move is fully compliant with the “Guidance Opinions on the Pilot Implementation of Employee Stock Ownership Plan by Listed Companies” and the Shanghai Stock Exchange’s STAR Market self-regulation guidelines.</p>\n<p>Management emphasized that ending the 2026 ESOP will not affect the company’s development strategy, business plans, financial position or operating results. The board further noted that no circumstances detrimental to shareholders’ interests have arisen from this decision.</p>\n<p>Looking ahead, Junshi Bio plans to continue refining its long-term incentive mechanisms in line with regulatory requirements, market conditions and the company’s operational needs to support sustainable growth.</p>\n<p>The resolution was approved by the Board on 26 August 2026 under the chairmanship of Mr. Xiong Jun.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01877","symbol_name":"君实生物","start_time":0,"source_url":"","article_id":"1114052435","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1114052435","pubTimestamp":1787740898,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio) announced that its Board of Directors has resolved to terminate the 2026 A-Share Employee Stock Ownership Scheme (ESOP) with immediate effect. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01877":"君实生物"},"translate_title":"君实生物终止2026年A股员工持股计划","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01877":1},"content_text":"Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio) announced that its Board of Directors has resolved to terminate the 2026 A-Share Employee Stock Ownership Scheme (ESOP) with immediate effect. The decision covers the cancellation of the ESOP itself, its administrative measures and all ancillary documents that had been adopted on 27 April 2026.\nAccording to the company, the termination aims to better safeguard the interests of the company, its shareholders and its employees. Junshi Bio stated that the move is fully compliant with the “Guidance Opinions on the Pilot Implementation of Employee Stock Ownership Plan by Listed Companies” and the Shanghai Stock Exchange’s STAR Market self-regulation guidelines.\nManagement emphasized that ending the 2026 ESOP will not affect the company’s development strategy, business plans, financial position or operating results. The board further noted that no circumstances detrimental to shareholders’ interests have arisen from this decision.\nLooking ahead, Junshi Bio plans to continue refining its long-term incentive mechanisms in line with regulatory requirements, market conditions and the company’s operational needs to support sustainable growth.\nThe resolution was approved by the Board on 26 August 2026 under the chairmanship of Mr. Xiong Jun.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"executive,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}